1. Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination. (October 2021) Authors: Roca, O.; Pacheco, A.; Rodon, J.; Antón, A.; Vergara-Alert, J.; Armadans, L.; Segalés, J.; Pumarola, T.; Campins, M.; Ferrer, R.; Rodríguez-Garrido, V. Journal: Journal of hospital infection Issue: Volume 116(2021) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 301 First-in-human phase I dose-escalation study of a MET/AXL/FGFR inhibitor, S 49076, in patients with advanced solid tumors. (September 2015) Authors: Azaro, A.; Rodon, J.; Herranz, M.; Nuciforo, P.; Prudkin, L.; Lopez-Busto, N.; Balandraud, S.; Cattan, V.; Jacquet-Bescond, A.; Marfai, L.; Pauly, J.; Postel-Vinay, S.; Hollebecque, A.; Soria, J.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Circulating Tumor DNA Dynamics Predict Outcomes of Systemic Therapy in Patients with Advanced Cancers. (October 2020) Authors: Gouda, M.; Huang, H.; Piha-Paul, S.; Call, S.G.; Karp, D.; Fu, S.; Naing, A.; Subbiah, V.; Pant, S.; Tsimberidou, A.M.; Hong, D.S.; Rodon, J.; Meric-Bernstam, F. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Transmission of 'Candidatus Phytoplasma pyri' by naturally infected Cacopsylla pyri to peach, an approach to the epidemiology of peach yellow leaf roll (PYLR) in Spain. (29th January 2018) Authors: Sabaté, J.; Rodon, J.; Artigues, M.; Laviña, A.; Batlle, A. Journal: Plant pathology Issue: Volume 67:Number 4(2018) Page Start: 978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Preliminary biomarker and pharmacokinetic analysis from the completed dose escalation part of the first-in-human Phase I study evaluating MP0250, a multi-DARPin® blocking HGF and VEGF-A, in patients with advanced solid tumors. (December 2016) Authors: Dawson, K.; Feurstein, D.; Fiedler, U.; Kuster, K.; Bez, M.; Schreiner, S.; Turner, D.; Tadjalli Mehr, K.; Stumpp, M.; Harstrick, A.; Baird, R.; Omlin, A.; Middleton, M.; Rodon, J.; Zitt, C. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer. (December 2016) Authors: Massard, C.; Azaro, A.; Soria, J.C.; Lassen, U.; Le Tourneau, C.; Smith, C.; Ohnmacht, U.; Oakley, G.; Patel, B.K.R.; Yuen, E.S.M.; Benhadji, K.A.; Rodon, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Early interventions to detect potential drug–drug interactions on patient eligibility for phase 1 clinical trials. (December 2016) Authors: Azaro, A.; Ghiglione, L.; Valdivia, C.; Munné, M.; Renedo, B.; Sabaté, N.; Alcalde, M.; Braña, I.; Hierro, C.; Martin-Liberal, J.; Ochoa de Olza, M.; Argiles Martínez, G.; Vilaró, M.; Tabernero, J.; Rodon, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗